SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
72.50
+0.30 (0.42%)
Mar 3, 2026, 1:00 PM CST
-28.22%
Market Cap 3.22B
Revenue (ttm) 1.30B
Net Income (ttm) 261.61M
Shares Out 44.59M
EPS (ttm) 5.85
PE Ratio 12.34
Forward PE n/a
Dividend 5.30 (7.23%)
Ex-Dividend Date Jul 21, 2025
Volume 15,576
Average Volume 28,665
Open 72.20
Previous Close 72.20
Day's Range 72.00 - 72.50
52-Week Range 70.50 - 110.00
Beta -0.14
RSI 48.53
Earnings Date Feb 24, 2026

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulc... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1982
Employees 227
Stock Exchange Taipei Exchange
Ticker Symbol 1777
Full Company Profile

Financial Performance

In 2025, SYN-TECH Chem. & Pharm.'s revenue was 1.30 billion, an increase of 3.39% compared to the previous year's 1.26 billion. Earnings were 261.61 million, a decrease of -33.48%.

Financial Statements

News

There is no news available yet.